Although FTC patients presented the highest levels of CFHR1 in this study, the sensitivity and specificity of CFHR1, CT, and Tg, and the combination of CFHR1+CT, to distinguish FTC from PTC were low (P > 0.05). The gene discussed is CFHR1; the disease is thyroid cancer, nonmedullary, 2.